Keiko M. Kang

<i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas

Koushik Muralidharan, Anudeep Yekula, Julia L. Small et al. · Clinical Cancer Research · 2020 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +17

Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma

Lan Wang, Anudeep Yekula, Koushik Muralidharan et al. · Cancers · 2020 · 16 citations · Full text

Medicine, Molecular Biology, Oncology +17

Arteriovenous malformation surgery in children: the Rady Children’s Hospital experience (2002–2019)

Jeffrey A. Steinberg, Michael G. Brandel, Keiko M. Kang et al. · Child s Nervous System · 2021 · 16 citations

Medicine, Pediatrics, Surgery +9

Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database

John Pham, David J. Coté, Keiko M. Kang et al. · Journal of Neuro-Oncology · 2025 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +16

Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis

Keiko M. Kang, Koushik Muralidharan, Anudeep Yekula et al. · Cancers · 2021 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17